AARD
Aardvark Therapeutics, Inc. Common Stock
stockNASDAQ
Market OpenOct 23, 2026 2:27:31 PM EDT
1.60USD-59.722%(-2.37)13,616,485
Pre-marketOct 23, 2026 9:29:30 AM EDT
2.94USD-25.758%(-1.02)
AARD Financials
In Q2 FY 2026 (ended ), Aardvark Therapeutics, Inc. Common Stock (AARD) reported net income of −$14.39M, operating cash flow of −$17.6M, and assets of $81.46M.
Loading financial statements…